
Uber will pay roughly $19 million in penalties in Australia after the country’s competition regulator found it misled riders by warning of cancellation charges even within a designated fee-free window, reported Reuters.
During a four-year period through late 2021, the ride-hailing app cautioned more than two million Australian customers seeking to cancel a trip within Uber’s free cancellation period that they might be charged a fee, likely leading riders to rethink their cancellation, the Australian Competition and Consumer Commission said on Tuesday. Most services including UberX have a five-minute window after a driver has accepted a trip for riders to cancel without facing any charge.
The regulator also found that for roughly two years, Uber’s app displayed inaccurate fare estimates for a now defunct UberTaxi ride option.
“Uber admits it misled Australian users for a number of years, and may have caused some of them to decide not to cancel their ride after receiving the cancellation warning, even though they were entitled to cancel free of charge under Uber’s own policy,” ACCC Chair Gina Cass-Gottlieb said.
The ACCC also said Uber admitted to have falsely represented fare estimates for its Uber Taxi option as its algorithm would almost always inflate the range and the actual fare would be lower than the company’s cheapest estimate.
“The misleading information on Uber’s app deprived consumers of a chance to make an informed decision about whether or not to choose the Uber Taxi option,” Cass-Gottlieb said.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas